- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Atezolizumab
Total 754 results
-
The Netherlands Cancer InstituteHoffmann-La RocheNot yet recruiting
-
Genentech, Inc.BioNTech SERecruiting
-
SanofiRecruitingNeoplasmUnited States, Canada, China, Korea, Republic of, Singapore
-
Abramson Cancer Center at Penn MedicineGenentech, Inc.Recruiting
-
InxMed (Shanghai) Co., Ltd.RecruitingMetastatic MelanomaUnited States, Australia
-
Hoffmann-La RocheActive, not recruitingCervical CancerItaly, Korea, Republic of, Canada, United States, Brazil, France, United Kingdom, Spain, Costa Rica, Russian Federation, Panama, Australia, Mexico, Peru, Poland, Taiwan, Thailand
-
Michael DillUniversity of Cologne; German Cancer Research Center; Heidelberg University; Universitätsmedizin... and other collaboratorsNot yet recruiting
-
Darell BignerNational Cancer Institute (NCI); Genentech, Inc.; Istari Oncology, Inc.Active, not recruiting
-
Centre Leon BerardRecruiting
-
NeoImmuneTechRoche Pharma AGActive, not recruitingCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Non Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small Cell Lung CarcinomaUnited States
-
Genentech, Inc.RecruitingLocally Advanced Solid Tumors | Metastatic Solid Tumors | Recurrent Solid TumorsAustralia, United States, Canada
-
University Medical Center GroningenActive, not recruitingLocally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 ExpressionNetherlands
-
Hoffmann-La RocheActive, not recruitingSquamous Cell Carcinoma of Head and NeckUnited States, Korea, Republic of, United Kingdom, Czechia, New Zealand, France, Spain, Greece, Thailand, Taiwan, Hungary, Italy, Poland
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung CancerHungary, Korea, Republic of, Australia, Spain, China, Denmark, Italy, Germany, Mexico, Poland, United States, Brazil, Peru, Thailand, Serbia, Switzerland, Japan, Turkey, Netherlands, Austria, Taiwan, Russian Federation, Ukraine, Greece
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingNon-small Cell Lung Cancer | Malignant Pleural MesotheliomaSwitzerland
-
University Hospital, BrestRoche Farma, S.A; Pierre Fabre Medicament; Groupe Français de Pneumo-CancérologieCompleted
-
University Hospital TuebingenTerminatedMalignant MelanomaGermany, France
-
Hoffmann-La RocheTerminatedAdvanced/Metastatic Head and Neck, Oesophageal and Cervical CancersKorea, Republic of, France, Spain, Belgium, United Kingdom, Singapore, Israel, Russian Federation, Taiwan, Switzerland, Turkey, United States, New Zealand, Poland, Germany
-
Hoffmann-La RocheCompletedRenal Cell CarcinomaKorea, Republic of, United States, France, Italy, United Kingdom, Canada, Australia, Brazil, Denmark, Spain, Turkey, Japan, Czechia, Singapore, Thailand, Taiwan, Russian Federation, Germany, Bosnia and Herzegovina, Poland, Mexico
-
Hoffmann-La RocheCompletedRenal Cell CarcinomaUnited States, Spain, Czechia, United Kingdom, Romania, France, Italy, Germany, Poland
-
Institut für Klinische Krebsforschung IKF GmbH...Roche Pharma AG; Thoraxklinik-Heidelberg gGmbHRecruitingNon-small Cell Lung CancerGermany
-
Uppsala University HospitalUnknown
-
European Lung Cancer Working PartyRecruitingCarcinoma, Non-Small-Cell Lung | ImmunotherapyBelgium
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerCanada, Belgium, Brazil, China, Denmark, Portugal, Spain, United Kingdom, Argentina, Bulgaria, Colombia, Germany, India, Ireland, Italy, Luxembourg, Mexico, Poland, Romania, Slovakia, Switzerland, Vietnam, Kazakhstan, Czechia
-
Palleos Healthcare GmbHRoche Pharma AG; University Hospital, Essen; University Hospital Erlangen; Phaon...Active, not recruitingTriple-negative Breast CancerGermany
-
Hoffmann-La RocheRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, China, Australia, Taiwan, Brazil, Japan, Argentina
-
University of Milano BicoccaAzienda Ospedaliera San Gerardo di MonzaRecruitingNon-small Cell Lung CancerItaly
-
Fundacion OncosurRecruitingCarcinoma, Small Cell LungSpain
-
Hoffmann-La RocheActive, not recruitingHepatocellular CarcinomaChina, Japan
-
West German Study GroupMerck Sharp & Dohme LLC; NanoString Technologies, Inc.Completed
-
Odonate Therapeutics, Inc.TerminatedBreast CancerUnited States, Korea, Republic of, Singapore
-
Stanford UniversityYale University; Janssen Scientific Affairs, LLCWithdrawn
-
ExelixisRecruitingColorectal CancerUnited States, Poland, Australia, Belgium, France, Hong Kong, Korea, Republic of, Spain, Hungary, Singapore, New Zealand, Germany, Thailand, Taiwan, Portugal, United Kingdom
-
SCRI Development Innovations, LLCGenentech, Inc.Active, not recruitingNon-Small Cell Lung Cancer | Solid TumorUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Chicago; Genentech, Inc.; Ohio State University; TargosActive, not recruitingUrothelial Carcinoma | Locally Advanced | UnresectableUnited States
-
Vyriad, Inc.TerminatedRecurrent Non-Small Cell Lung CancerUnited States
-
Megan Daly, MDGenentech, Inc.Active, not recruitingStage I Non-Small Cell Lung CancerUnited States
-
Genentech, Inc.Active, not recruitingLymphocytic Leukemia, Chronic | Lymphoma, Non HodgkinUnited States, Korea, Republic of, Australia, United Kingdom, Germany, Canada, Spain
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Active, not recruitingBladder Cancer | Urothelial Carcinoma | Metastatic Bladder CancerUnited States
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, United Kingdom, Australia, Belgium, Brazil, Canada, China, Portugal, Spain, France, Germany, Poland, Hong Kong, Israel, Thailand, Turkey, Japan, Austria, Hungary, Italy, Taiwan, Netherlands, Greece, New... and more
-
Grand Hôpital de CharleroiCliniques universitaires Saint-Luc- Université Catholique de LouvainActive, not recruiting
-
Stichting Hemato-Oncologie voor Volwassenen NederlandActive, not recruitingNHL | DLBCLNetherlands, Belgium
-
Gilead SciencesCompletedHepatitis CUnited States, Puerto Rico
-
Inovio PharmaceuticalsActive, not recruitingUrothelial CarcinomaUnited States, Spain
-
ExelixisActive, not recruitingA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (STELLAR-001)Renal Cell Carcinoma | Colorectal Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States, Australia, Belgium, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Hoffmann-La RocheCompletedGynecologic NeoplasmsSpain, France, Australia, United Kingdom
-
Hoffmann-La RocheCompleted
-
Treos Bio LimitedMayo Clinic; Hoffmann-La RocheActive, not recruitingColorectal Cancer MetastaticUnited States
-
SanofiTerminatedNeoplasmSpain, Taiwan, Italy, Czechia, United States, Belgium, Canada, Netherlands
-
Matthew GalskyGenentech, Inc.CompletedUrothelial/Bladder Cancer, NosUnited States